Loading stock data…
DOC
$16.42+0.25 (+1.55%)
Market ClosedLast close May 1
Healthpeak Properties, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Healthpeak Properties, Inc. in the Real Estate sector is trading at $16.42. The stock is currently near its 52-week low of $15.70, remaining 3.0% below its 200-day moving average. Technical signals show neutral RSI of 50 and bearish MACD signal, explaining why DOC maintains its current current market pressure. The Whystock Score of 30/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 50) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$16.42
Potential Downside
88.7%
Whystock Fair Value$1.85
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus18 analysts
Buy
Mean target$19.47+18.6%
Range$16.00 – $29.00
Fundamentals
Healthpeak Properties, Inc. is a Standard & Poor's 500 company that owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery in the United States. Our company was originally founded in 1985. We are organized ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$11.35B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
163.30
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.08
Div Yield
Strong income play. Yield provides a meaningful total return floor.
741.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
2.20%
Volume
Today's trading volume
9.55M
Recent News
FinWise Bancorp (FINW) Lags Q1 Earnings and Revenue Estimates
FinWise Bancorp (FINW) delivered earnings and revenue surprises of -38.46% and -19.15%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
3 Healthcare Stocks Paying the Highest Dividends in the Sector Right Now
The highest-yielding healthcare stocks come with some side effects.
20 Years on Wall Street Taught Me: Build a Massive Dividend Portfolio With Stocks Under $20
After a 35-year career in the financial industry, including two decades as an institutional stockbroker at Bear Stearns, Lehman Brothers, and Morgan Stanley, I developed an institutional perspective on dividend-focused investing. My tenure at these premier Wall Street firms exposed me to fundamental analysis, credit evaluation, and risk management practices, which directly translate into selecting ... 20 Years on Wall Street Taught Me: Build a Massive Dividend Portfolio With Stocks Under $20
DOC or NHI: Which Is the Better Value Stock Right Now?
DOC vs. NHI: Which Stock Is the Better Value Option?
Key Reasons to Add Healthpeak Properties Stock to Your Portfolio Now
DOC gains from strong lab demand and rising senior healthcare needs, supported by portfolio repositioning and solid balance sheet strength.